Metabolic (dysfunction)-associated fatty liver disease (MAFLD) affects up to a third of the
global population; its burden has grown in parallel with rising rates of type 2 diabetes …

Description Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading
etiology for chronic liver disease, affecting> 25% of the US and global populations. Up to 1 …

Cirrhosis causes a heavy global burden. In this review, we summarized up-to-date
epidemiological features of cirrhosis and its complications. Recent epidemiological studies …

Background The incidence of non-alcoholic fatty liver disease (NAFLD) is rapidly increasing
worldwide parallel to the global obesity epidemic. NAFLD encompasses a range of liver …

Background & Aims Nonalcoholic fatty liver disease (NAFLD) is traditionally associated with
obesity. However, there is a subtype of NAFLD, namely NAFLD in lean, that occurs without …

Asian Americans (AsA), Native Hawaiians, and Pacific Islanders (NHPI) comprise 7.7% of
the US population, and AsA have had the fastest growth rate since 2010. Yet the National …

Lean individuals with NAFLD have more severe liver disease a... : Hepatology Lean individuals
with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study) …

Background & Aims Although approximately 40% of patients with nonalcoholic fatty liver
disease (NAFLD) are nonobese or lean, little is known about the long-term clinical outcomes …

Summary Background & Aims Non‐alcoholic fatty liver disease (NAFLD) can develop in
individuals who are not overweight. Whether lean persons with NAFLD have lower mortality …

The ability to determine the prognosis of lean nonalcoholic fatty liver disease (NAFLD) is
essential for decision making in clinical settings. Using a large community‐based Chinese …